Hims & Hers Health HIMS EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Hims & Hers Health’s reported figures.
The official record: Hims & Hers Health’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Hims & Hers Health's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Hims & Hers Health's EBITDA?
- Hims & Hers Health (HIMS) reported EBITDA of -$56.37M in Q1 2026.
- How has Hims & Hers Health's EBITDA changed year-over-year?
- Hims & Hers Health's EBITDA decreased by 185.2% year-over-year, from $66.17M to -$56.37M.
- What is the long-term trend for Hims & Hers Health's EBITDA?
- Over 4 years (2021 to 2025), Hims & Hers Health's EBITDA has grown at a 9.6% compound annual growth rate (CAGR), from -$110.97M to $160.12M.
- What does EBITDA mean?
- Operating cash profit before interest, taxes, and non-cash charges.
- How do you interpret EBITDA?
- Higher is better and widely used to value capital-intensive businesses, but it ignores the real cost of capex — pair it with free cash flow. (Defined as EBIT + D&A so EBITDA = EBIT + D&A holds exactly.)
- How does EBITDA compare across companies?
- Standard cross-company operating-profit proxy for non-financials; not meaningful for banks and insurers.